Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$207,800.00

A tissue engineering platform to identify target combinations in tumour stoma to render tumours therapy sensitive

EF 2015-16

Résumé
Survival rates for many cancer types are poor and there is a need for new therapies to be developed. A major challenge faced by drug companies is identifying the most promising drugs that will be effective in patients. Currently new drugs are tested on cells cultured in 2D plastic dishes. Studies using this approach however, do not accurately predict how well the drug will work in patients. One reason contributing to the poor predictability of 2D dishes is that the environment is very different from that in a real tumor in a patient and cell properties (and how they respond to a drug) are strongly dependent on their local environment. A need exists for models that better recapitulate the tumor environment and allow an accurate assessment of new drug to ensure the most promising therapies reach patients faster. We have developed a strategy to engineer artificial tumours in which such analysis is possible. Here we will assess the benefits of our new approach compared to standard 2D dishes and then use our platform to test the effectiveness of new drugs to treat head and neck cancer.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
336768
Name
McGuigan Alison P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
A tissue engineering platform to identify target combinations in tumour stoma to render tumours therapy sensitive
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$207,800
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
1101; 1901; Biomedical Technology; Head And Neck Carcinoma; Human Health; Hypoxia; In Vitro Tissue Models; Stroma; Therapeutic Antibodies; Tumor Microenvironment
Abstract
Survival rates for many cancer types are poor and there is a need for new therapies to be developed. A major challenge faced by drug companies is identifying the most promising drugs that will be effective in patients. Currently new drugs are tested on cells cultured in 2D plastic dishes. Studies using this approach however, do not accurately predict how well the drug will work in patients. One reason contributing to the poor predictability of 2D dishes is that the environment is very different from that in a real tumor in a patient and cell properties (and how they respond to a drug) are strongly dependent on their local environment. A need exists for models that better recapitulate the tumor environment and allow an accurate assessment of new drug to ensure the most promising therapies reach patients faster. We have developed a strategy to engineer artificial tumours in which such analysis is possible. Here we will assess the benefits of our new approach compared to standard 2D dishes and then use our platform to test the effectiveness of new drugs to treat head and neck cancer.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
McGuigan, Alison P; Wouters, Bradly
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $207,800~ $0~